Evidence that the median raphe nucleus-dorsal hippocampal pathway mediates diazepam withdrawal-induced anxiety

Psychopharmacology

Volumn 130, Issue 3, 1997, Pages 228-234

  Andrews, Nick ^a,b   File, Sandra E ^a   Fernandes, Cathy ^a   Gonzalez, Luis E ^a   Barnes, Nicholas M ^b  

^a GUY S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

anxiety; benzodiazepine withdrawal 5 HT release; hippocampus; in vivo mirodialysis; median raphe nucleus

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; DIAZEPAM; POTASSIUM ION; RADIOISOTOPE; SEROTONIN; SEROTONIN 1A AGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; DRUG WITHDRAWAL; HIPPOCAMPUS; HISTOLOGY; INTRACEREBRAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MEDIAN RAPHE NUCLEUS; MICROINJECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE; SOCIAL INTERACTION; WITHDRAWAL SYNDROME;

ANIMALS; DIAZEPAM; HIPPOCAMPUS; INTERPERSONAL RELATIONS; MALE; NEURAL PATHWAYS; RAPHE NUCLEI; RATS; SEROTONIN; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0030945328     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050233     Document Type: Article

References (37)

1. Abernethy DR, Greenblatt DJ, Shader RI (1981) Treatment of diazepam withdrawal syndrome with propranolol. Ann Int Med 94:354-355
2. 3 receptor ligands following chronic diazepam treatment. Psychopharmacology 108:333-337
3. Andrews N, File SE (1993) Increased 5-HT release mediates the anxiogenic response during benzodiazepine withdrawal: a review of the supporting neurochemical and behavioural evidence. Psychopharmacology 112:21-25
4. 2+ uptake in diazepam withdrawal: inhibition by baclofen. Pharmacol Biochem Behav 41:695-699
5. Andrews N, Barnes NM, Steward LJ, West KE, Cunningham J, Wu PY, Zangrossi Jr H, File SE (1993) A comparison of rat brain amino acid and monoamine content in diazepam withdrawal and after exposure to a phobic stimulus. Br J Pharmacol 109:171-174
6. 1A receptors in the median raphe nucleus and dorsal hippocampus may mediate anxiolytic and anxiogenic behaviours respectively. Eur J Pharmacol 264:259-264
7. Ashton CH, Rawlins MD, Tyrer SP (1990) A double-blind placebo-controlled study of buspirone in diazepam withdrawal in chronic benzodiazepine users. Br J Psychiatry 157:232-238
8. Azmitia EC, Segal M (1978) An autoradiographic analysis of the differential ascending projections of the dorsal and raphé nuclei in the rat. J Comp Neurol 179:641-668
9. Baldwin HA, Hitchcott PK, File SE (1989) Evidence that the increased anxiety detected in the elevated plus-maze during chlordiazepoxide withdrawal is not due to enhanced noradrenergic activity. Pharmacol Biochem Behav 34:931-933
10. Barnes NM, Cheng CH, Costall B, Ge J, Naylor RJ (1992) Differential modulation of extracellular levels of 5-hydroxytryptamine in the rat frontal cortex by (R)- and (S)-zacopride. Psychopharmacology 107:233-239
11. Bosker F, Klompmakers A, Westenberg H (1994) Extracellular 5-hydroxytryptamine in median raphe nucleus of the conscious rat is decreased by nanomolar concentrations of 8-hydroxy-2-(di-n-propylamino) tetralin and is sensitive to tetrodotoxin. J Neurochem 63:2165-2171
12. 10 dopamine regions of rat brain: characterization and responsiveness to cocaine. J Pharmacol Exp Ther 267:379-389
13. Costall B, Jones BJ, Kelly ME, Naylor RJ, Oakley NR, Onaivi ES, Tyers MB (1989) The effects of ondansetron (GR38032F) in rats and mice treated subchronically with diazepam. Pharmacol Biochem Behav 34:769-778
14. Costall B, Jones BJ, Kelly ME, Naylor RJ, Onaivi ES, Tyers MB (1990) Sites of action of ondansetron to inhibit withdrawal from drugs of abuse. Pharmacol Biochem Behav 36:97-104
15. Deakin JFW, Graeff FG (1991) 5-HT and mechanisms of defence. J Psychopharmacol 5:305-315
16. Delle Chiaie R, Pancheri P, Casacchia M, Stratta P, Kotzalidis GD, Zibellini M (1995) Assessment of the efficacy of buspirone in patients affected by generalised anxiety disorder, shifting to buspirone from prior treatment with lorazepam: a placebo-controlled, double-blind study. J Clin Psychopharmacol 15:12-19
17. File SE (1980) The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. J Neurosci Methods 2:219-238
18. File SE (1990) The history of benzodiazepine dependence: a review of animal studies. Neurosci Biobehav Rev 14:135-146
19. File SE (1993) The social interaction test of anxiety. Neurosci Protocols 1:1-7
20. File SE, Andrews N (1991) Low but not high doses of buspirone reduce the anxiogenic effects of diazepam withdrawal. Psychopharmacology 105:578-582
21. File SE, Mabbutt PS, Andrews NA (1991) Diazepam withdrawal responses measured in the social interaction test of anxiety and their reversal by baclofen. Psychopharmacology 104:62-66
22. File SE, Andrews N, Zangrossi H (1993) Tianeptine counteracts the anxiogenic effects of benzodiazepine withdrawal, but not those of exposure to cat odour. Eur J Psychiatry 8:75s-80s
23. Gibson EL, Barnfield AMC, Curzon G (1996) Dissociation of chronic diazepam treatment and withdrawal on hippocampal dialysate 5-HT and mCPP-induced anxiety in rats. Behav Pharmacol 7:185-193
24. 1A and benzodiazepine receptors in the basolateral amygdala modulate anxiety in the social interaction test, but not in the elevated plus-maze. Brain Res 732:145-153
25. 1A receptor agonists in two models of anxiety after dorsal raphe injection. Psychopharmacology 106:261-267
26. Hitchcott PK, File SE, Little HJ, Null DJ (1989) Diazepam withdrawal: decreased seizure threshold and increased anxiety reversed by FG 7142 and flumazenil. Soc Neurosci Abstr 15: 414P
27. 14C]-γ-aminobutyric acid release. Br J Pharmacol 99: 11-12
28. Hogg S, Andrews N, File SE (1994) Contrasting behavioural effects of 8-OH DPAT in the dorsal raphé nucleus and ventral hippocampus. Neuropharmacology 33:343-348
29. Hollister LE, Motzenbecker FP. Degan RO (1961) Withdrawal reactions from chlordiazepoxide (Librium). Psychopharmacologia 2:63-68
30. Kunchandy K, Kulkarni SK (1986) Reversal by alpha-2 agonists of diazepam withdrawal hyperactivity in rats. Psychopharmacology 90:198-202
31. Paxinos G, Watson CH (1986) The rat brain in stereotaxic coordinates. Academic Press, London
32. Peturrson H, Lader MH (1981) Withdrawal from long term benzodiazepine treatment. BMJ 283:643-645
33. Rickels K, Case WG, Schweizer E (1991) Management of benzodiazepine discontinuation. In: Racagni C, Brunello N, Fukuda T (eds) Biological psychiatry, vol 1. Excerpta Medica, pp 778-779
34. Sharp T, Bramwell SR, Clark D, Grahame-Smith DG (1990) In vivo measurement of extra-cellular 5-hydroxytryptamine in hippocampus of the anesthetised rat using microdialysis: changes in relation to 5-hydroxytryptaminergic neuronal activity. J Neurochem 53:234-240
35. 1B agonists. Synapse 1:3-9
36. Tyrer P (1988) Dependence as a limiting factor in the clinical use of minor tranquillisers. Pharmacol Ther 36:173-188
37. Upton N, Stean TO, Blackburn TP (1993) BRL 46470A, a selective 5-HT3 receptor antagonist, attenuates the increased seizure susceptibility observed during diazepam-induced withdrawal in mice. Br J Pharmacol 108:254